MIM

Monashee Investment Management Portfolio holdings

AUM $190M
This Quarter Return
+11.25%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$472M
AUM Growth
+$472M
Cap. Flow
+$0
Cap. Flow %
0%
Top 10 Hldgs %
37.41%
Holding
262
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 21.74%
2 Real Estate 12.26%
3 Technology 11.11%
4 Energy 9.46%
5 Financials 5.47%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CRSP icon
26
CRISPR Therapeutics
CRSP
$4.8B
– –
0
– –
ADC icon
27
Agree Realty
ADC
$7.95B
– –
0
– –
PETQ
28
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
– –
0
– –
SKY icon
29
Champion Homes, Inc.
SKY
$4.31B
– –
0
– –
ZLAB icon
30
Zai Lab
ZLAB
$3.51B
– –
0
– –
EB icon
31
Eventbrite
EB
$264M
– –
0
– –
EVOP
32
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
– –
0
– –
SPAQ.U
33
DELISTED
Spartan Energy Acquisition Corp Units (each consisting of one Class A Common Stock and one-third of
SPAQ.U
– –
0
– –
TLYS icon
34
Tilly's
TLYS
$60.6M
– –
0
– –
VKTX icon
35
Viking Therapeutics
VKTX
$3B
– –
0
– –
RNST icon
36
Renasant Corp
RNST
$3.69B
– –
0
– –
ECYT
37
DELISTED
Endocyte, Inc. Common Stock
ECYT
– –
0
– –
FND icon
38
Floor & Decor
FND
$8.44B
– –
0
– –
IIN
39
DELISTED
IntriCon Corporation
IIN
– –
0
– –
DRNA
40
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
0
– –
TSLX icon
41
Sixth Street Specialty
TSLX
$2.32B
– –
0
– –
SAGE
42
DELISTED
Sage Therapeutics
SAGE
– –
0
– –
VTAK icon
43
Catheter Precision
VTAK
$3.09M
– –
0
– –
PGTI
44
DELISTED
PGT, Inc.
PGTI
– –
0
– –
NXEOW
45
DELISTED
Nexeo Solutions, Inc. Warrant
NXEOW
– –
0
– –
FATE icon
46
Fate Therapeutics
FATE
$115M
– –
0
– –
CLPR
47
Clipper Realty
CLPR
$68.8M
– –
0
– –
FSCT
48
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
– –
0
– –
USAC icon
49
USA Compression Partners
USAC
$2.91B
– –
0
– –
RP
50
DELISTED
RealPage, Inc.
RP
– –
0
– –
1
2
3 4 5